Epidemiology, treatment patterns, and disease burden of cytomegalovirus in hematopoietic cell transplant recipients in selected countries outside of Europe and North America: A systematic review

Abstract

AbstractBackgroundCytomegalovirus (CMV) disease impacts morbidity and mortality in hematopoietic cell transplant (HCT) recipients. This systematic review summarized data on the epidemiology, management, and burden of CMV post‐HCT outside of Europe and North America.MethodsThe MEDLINE, Embase, and Cochrane databases were searched for observational studies and treatment guidelines in HCT recipients across 15 selected countries from Asia‐Pacific, Latin America, and Middle East (search period: 1 January 2011–17 September 2021). Outcomes included incidence of CMV infection/disease, recurrence, risk factors, CMV‐related mortality, treatments, refractory, resistant CMV, and burden.ResultsOf 2708 references identified, 68 were eligible (67 studies and one guideline; 45/67 studies specific to adult allogeneic HCT recipients). The rates of CMV infection and disease within 1 year of allogeneic HCT were 24.9%–61.2% (23 studies) and 2.9%–15.7% (10 studies), respectively. Recurrence occurred in 19.8%–37.9% of cases (11 studies). Up to 10% of HCT recipients died of CMV‐related causes. In all countries, first‐line treatment for CMV infection/disease involved intravenous ganciclovir or valganciclovir. Conventional treatments were associated with serious adverse events such as myelosuppression (10.0%) or neutropenia only (30.0%, 39.8%) and nephrotoxicity (11.0%) (three studies), frequently leading to treatment discontinuation (up to 13.6%). Refractory CMV was reported in 2.9%, 13.0%, and 28.9% of treated patients (three studies) with resistant CMV diagnosed in 0%–10% of recipients (five studies). Patient‐reported outcomes and economic data were scarce.ConclusionThe incidence of CMV infection and disease post‐HCT is high outside of North America and Europe. CMV resistance and toxicity highlight a major unmet need with current conventional treatments. image